Cytokinetics director B. Lynne Parshall sells $273,634 in shares

B. Lynne Parshall, a director at Cytokinetics Inc., sold 5,000 shares of common stock valued at $273,634 on November 9, 2026, according to a regulatory filing. This sale comprised two separate transactions: the first involved the sale of 2,445 shares at a weighted average price of $54.17 per share, while the second entailed the sale of 2,555 shares at a weighted average price of $55.26 per share.

These transactions resulted in the disposition of approximately $132,448 and $141,195, respectively. Following these sales, Ms. Parshall still holds 5,784 shares of Cytokinetics common stock. Notably, Cytokinetics' stock is currently trading at $56.16, which is only slightly above its 52-week low of $53.55. Despite this insider sale, the company's stock appears undervalued based on market conditions, with a market capitalization of $7.82 billion.